Found 1 articles for: "Ruxolitinib Therapy"

Successful Management of Erythema Dyschromicum Perstans Following Topical Ruxolitinib Therapy

March 2023 | Volume 22 | Issue 3 | Case Reports | 297 | Copyright © March 2023

Erythema dyschromicum perstans (EDP) is a rare cutaneous disorder in which patients develop gray or blue-brown macules or patches on their bodies.¹ This condition does not appear to have a ...
Read More